Facebook
X
LinkedIn
ForwardAdvancing CSU Management Through Empathy and Evidence
Chronic spontaneous urticaria (CSU) places a substantial and often overlooked burden on patients, leading to delays in diagnosis, inadequate symptom control, and significant unmet needs despite advances in treatment. This program empowers clinicians with up-to-date, patient-centered strategies to improve diagnosis and management of CSU. Through a combination of patient insights and expert-led discussions, participants will explore strategies to align care with the latest evidence, treatment goals, and patient preferences. Interactive communication-focused scenarios will model effective conversations that address misconceptions, barriers to care, and the emotional impact of CSU, highlighting the value of interprofessional collaboration. Participants will leave with actionable approaches to optimize outcomes and enhance the patient experience across the CSU care continuum.
Educational Partner: Vindico Medical Education
Medium: Online
Commercial Support: This activity is supported by independent medical education grants from Novartis Pharmaceuticals, Inc.; Sanofi and Regeneron Pharmaceuticals.
Target Audience
The intended audience for this activity is physicians and advanced practice providers specializing in allergy, dermatology, and primary care, involved in the management of patients with CSU.
Learning Objectives
Upon completion of this activity, learners will be able to:
- Recognize the multifaceted burden of CSU on patient quality of life.
- Identify patients with CSU in a timely manner.
- Select treatment for patients with refractory CSU based on the latest evidence, treatment goals, and patient preferences.
- Use interprofessional collaboration to improve outcomes for patients with CSU.
ACTIVITY CO-CHAIRS
David M. Lang, MD, FAAAAI
Emeritus Chair
Department of Allergy and Clinical Immunology
Cleveland Clinic
Cleveland, OH
Emeritus Chair
Department of Allergy and Clinical Immunology
Cleveland Clinic
Cleveland, OH
Giselle Mosnaim, MD, MS, FAAAAI, FACAAI
Director of Allergy and Immunology Research
Department of Medicine
Endeavor Health
Clinical Professor of Medicine
University of Chicago, Pritzker School of Medicine
Chicago, IL
Director of Allergy and Immunology Research
Department of Medicine
Endeavor Health
Clinical Professor of Medicine
University of Chicago, Pritzker School of Medicine
Chicago, IL
FACULTY
Dennis K. Ledford, MD, FAAAAI, FACAAI, LCP
Ellsworth and Mabel Simmons Professor of Allergy and Immunology
Morsani College of Medicine, University of South Florida
Section Chief, Allergy/Immunology
James A. Haley VA Hospital
Tampa, FL
Ellsworth and Mabel Simmons Professor of Allergy and Immunology
Morsani College of Medicine, University of South Florida
Section Chief, Allergy/Immunology
James A. Haley VA Hospital
Tampa, FL
Ricardo A. Tan, MD, FAAAAI, FACAAI
Owner, California Allergy and Asthma Medical Group
Past President, Los Angeles Society of Allergy, Asthma and Clinical Immunology
Los Angeles, CA
Owner, California Allergy and Asthma Medical Group
Past President, Los Angeles Society of Allergy, Asthma and Clinical Immunology
Los Angeles, CA
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University Of Chicago Pritzker School Of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Registration: To view this activity, visit the main activity page.
If you are logged in, click on the "Complete Activity" button below!
If you are logged in, click on the "Complete Activity" button below!
Please login or create an account to proceed.